Silence Therapeutics

In News

Silence brings the noise to Takeda with phase 2 blood cancer win - Fierce Biotech

Fierce Biotech - Aug 10, 2026

Silence Therapeutics Locks In $175 Million to Fuel siRNA Pipeline After Upsized ADS Offering - BioPharm International

BioPharm International - Aug 13, 2026

Silence Therapeutics aims at Takeda with new data in rare blood cancer - STAT

STAT - Aug 10, 2026

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares - Business Wire

Business Wire - Aug 10, 2026

Silence Therapeutics shares surge ahead of divesiran Phase 2 results call - Yahoo Finance

Yahoo Finance - Aug 10, 2026

Silence Therapeutics: Making Some Recent Noise (NASDAQ:SLN) - Seeking Alpha

Seeking Alpha - Aug 19, 2026

Silence Therapeutics' siRNA hits the mark in polycythemia vera - The Pharma Letter

The Pharma Letter - Aug 11, 2026

Silence Therapeutics progresses rare blood cancer siRNA with positive trial results - BioXconomy

BioXconomy - Aug 21, 2026

Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing - PharmExec.com

PharmExec.com - Aug 13, 2026

Silence Therapeutics closes $201.3M public offering - Investing.com

Investing.com - Aug 14, 2026

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs - Business Wire

Business Wire - Aug 14, 2026

FDA panel to weigh Grail’s Galleri test - STAT

STAT - Aug 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment